PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGEXR)
Abstract
Authors
C Renaudin S Roze WJ Valentine AJ Palmer